U.S. markets closed

Pharmadrug Inc. (LMLLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0689+0.0010 (+1.47%)
At close: 3:28PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 1/9/2021
Current
9/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
11.64M4.41M4.46M881.07k1.59M
Enterprise Value 3
12.16M5.58M6.69M2.66M3.53M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
15.264.325.492.082.87
Price/Book (mrq)
1.510.862.440.280.39
Enterprise Value/Revenue 3
22.2640.6634.7814.9193.07
Enterprise Value/EBITDA 6
-2.35-9.59-5.7113.74-0.88

Trading Information

Stock Price History

Beta (5Y Monthly) 3.86
52-Week Change 3182.92%
S&P500 52-Week Change 313.47%
52 Week High 30.1300
52 Week Low 30.0021
50-Day Moving Average 30.0597
200-Day Moving Average 30.0343

Share Statistics

Avg Vol (3 month) 3231.2k
Avg Vol (10 day) 3188.98k
Shares Outstanding 5196.6M
Float 183.54M
% Held by Insiders 15.40%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.63%
Return on Equity (ttm)-72.31%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)-49.40%
Gross Profit (ttm)253.25k
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.1490
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)16.57
Current Ratio (mrq)2.20
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A